Oncocyte Corporation
NASDAQ:OCX 3:59:28 PM EDT
Earnings Announcements
OncoCyte Reports First Quarter 2022 Financial Results
Published: 05/11/2022 20:58 GMT
Oncocyte Corporation (OCX) - Oncocyte Reports First Quarter 2022 Financial Results.
Q1 Loss per Share $0.11.
Q1 Revenue $1.4 Million.
Q1 Loss per Share $0.11.
Q1 Revenue $1.4 Million.
Revenue is expected to be $2.71 Million
Adjusted EPS is expected to be -$0.12
Next Quarter Revenue Guidance is expected to be $2.23 Million
Next Quarter EPS Guidance is expected to be -$0.12
More details on our Analysts Page.
Adjusted EPS is expected to be -$0.12
Next Quarter Revenue Guidance is expected to be $2.23 Million
Next Quarter EPS Guidance is expected to be -$0.12
More details on our Analysts Page.